Related Experiment Video
Updated: May 30, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Estrogen sulfotransferase inhibits adipocyte differentiation
Taira Wada1, Chibueze A Ihunnah, Jie Gao
1Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
Estrogen sulfotransferase (EST) inhibits adipocyte differentiation by activating ERK1/2 MAPK and blocking insulin signaling. This enzyme is a key negative regulator of adipogenesis, impacting fat cell development.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolism
Background:
- Estrogen sulfotransferase (EST) is a phase II enzyme catalyzing estrogen sulfoconjugation.
- EST is abundant in white adipose tissue, but its role in adipocyte development is unclear.
Purpose of the Study:
- To investigate the role of EST in adipocyte differentiation and function.
Main Methods:
- Studied EST expression in 3T3-L1 and primary mouse preadipocytes.
- Utilized EST overexpression and knockout models in vitro and in vivo.
- Assessed adipogenesis, ERK1/2 MAPK signaling, and insulin signaling pathways.
Main Results:
- EST expression decreased during adipocyte differentiation.
- EST overexpression inhibited adipogenesis, while EST knockout enhanced it.
- EST's inhibitory effect required enzymatic activity and involved sustained ERK1/2 activation and impaired insulin signaling.
Conclusions:
- EST acts as a negative regulator of adipogenesis.
- EST influences adipocyte size and fat tissue development.
Related Concept Videos
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
